Atezolizumab/nivolumabType 1 diabetes mellitus: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1688卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41670-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[41] AlemtuzumabType 1 diabetes mellitus and autoimmune thyroiditis: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 21 - 21
[42] ClozapineType 2 diabetes mellitus: 2 case reports
Reactions Weekly, 2005, 1061 (1) : 8 - 8
[43] ClozapineType 2 diabetes mellitus: 2 case reports
Reactions Weekly, 2002, 890 (1) : 8 - 8
[44] SomatrogonWorsening of diabetes mellitus and worsening of type 2 diabetes mellitus: 2 case reports
Reactions Weekly, 2020, 1788 (1) : 209 - 209
[45] Ipilimumab/nivolumabType 1 diabetes and pseudogout: case report
Reactions Weekly, 2019, 1757 (1) : 179 - 179
[46] TacrolimusType 1 diabetes mellitus: 5 case reports
Reactions Weekly, 1998, 699 (1) : 10 - 11
[47] PembrolizumabType 1 diabetes mellitus: 5 case reports
Reactions Weekly, 2020, 1824 (1) : 239 - 239
[48] InsulinType 1 diabetes mellitus: 6 case reports
Reactions Weekly, 2009, 1275 (1) : 20 - 20
[49] AntineoplasticsType 1 diabetes mellitus: 10 case reports
Reactions Weekly, 2023, 1948 (1) : 61 - 61
[50] Atezolizumab/durvalumabMyositis: 2 case reports
Reactions Weekly, 2024, 2021 (1) : 90 - 90

← 1 2 3 4 5 →